# Glyburide vs Glucovance in the Treatment of GDM

> **NCT02726490** · EARLY_PHASE1 · TERMINATED · sponsor: **Texas Tech University Health Sciences Center, El Paso** · enrollment: 7 (actual)

## Conditions studied

- Gestational Diabetes

## Interventions

- **DRUG:** Glyburide
- **DRUG:** Glucovance

## Key facts

- **NCT ID:** NCT02726490
- **Lead sponsor:** Texas Tech University Health Sciences Center, El Paso
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07
- **Primary completion:** 2018-08-14
- **Final completion:** 2018-08-14
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of Recruitment
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02726490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02726490, "Glyburide vs Glucovance in the Treatment of GDM". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02726490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*